Global Glaucoma Therapeutics Devices Market Growth 2025-2031

Publication ID:

LPI06260100

Publication Date:

June 12, 2025

Pages:

144

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Glaucoma Therapeutics Devices market size is predicted to grow from US$ 7852 million in 2025 to US$ 10640 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.
United States market for Glaucoma Therapeutics Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Glaucoma Therapeutics Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Glaucoma Therapeutics Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Glaucoma Therapeutics Devices players cover Alcon, Carl Zeiss Meditec AG, Johnson & Johnson Vision, Bausch Health Companies Inc., Glaukos Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淕laucoma Therapeutics Devices Industry Forecast鈥� looks at past sales and reviews total world Glaucoma Therapeutics Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Glaucoma Therapeutics Devices sales for 2025 through 2031. With Glaucoma Therapeutics Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glaucoma Therapeutics Devices industry.
This Insight Report provides a comprehensive analysis of the global Glaucoma Therapeutics Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glaucoma Therapeutics Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Glaucoma Therapeutics Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glaucoma Therapeutics Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glaucoma Therapeutics Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Glaucoma Therapeutics Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Surgical Devices
Non-surgical Devices
Segmentation by Application:
Hospitals
Ophthalmic Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Carl Zeiss Meditec AG
Johnson & Johnson Vision
Bausch Health Companies Inc.
Glaukos Corporation
Topcon Corporation
STAAR Surgical Company
NIDEK CO., LTD.
Lumenis Ltd.
Ophthalmic Instrument Company
New World Medical, Inc.
Ellex Medical Lasers Limited
Iridex Corporation
Abbvie Inc.
Reichert Technologies
Ziemer Ophthalmic Systems
Optovue, Inc.
Heidelberg Engineering GmbH
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glaucoma Therapeutics Devices market?
What factors are driving Glaucoma Therapeutics Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glaucoma Therapeutics Devices market opportunities vary by end market size?
How does Glaucoma Therapeutics Devices break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glaucoma Therapeutics Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Glaucoma Therapeutics Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Glaucoma Therapeutics Devices by Country/Region, 2020, 2024 & 2031
2.2 Glaucoma Therapeutics Devices Segment by Type
2.2.1 Surgical Devices
2.2.2 Non-surgical Devices
2.3 Glaucoma Therapeutics Devices Sales by Type
2.3.1 Global Glaucoma Therapeutics Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Glaucoma Therapeutics Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Glaucoma Therapeutics Devices Sale Price by Type (2020-2025)
2.4 Glaucoma Therapeutics Devices Segment by Application
2.4.1 Hospitals
2.4.2 Ophthalmic Clinics
2.4.3 Others
2.5 Glaucoma Therapeutics Devices Sales by Application
2.5.1 Global Glaucoma Therapeutics Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Glaucoma Therapeutics Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Glaucoma Therapeutics Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Glaucoma Therapeutics Devices Breakdown Data by Company
3.1.1 Global Glaucoma Therapeutics Devices Annual Sales by Company (2020-2025)
3.1.2 Global Glaucoma Therapeutics Devices Sales Market Share by Company (2020-2025)
3.2 Global Glaucoma Therapeutics Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Glaucoma Therapeutics Devices Revenue by Company (2020-2025)
3.2.2 Global Glaucoma Therapeutics Devices Revenue Market Share by Company (2020-2025)
3.3 Global Glaucoma Therapeutics Devices Sale Price by Company
3.4 Key Manufacturers Glaucoma Therapeutics Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glaucoma Therapeutics Devices Product Location Distribution
3.4.2 Players Glaucoma Therapeutics Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Glaucoma Therapeutics Devices by Geographic Region
4.1 World Historic Glaucoma Therapeutics Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Glaucoma Therapeutics Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Glaucoma Therapeutics Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glaucoma Therapeutics Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Glaucoma Therapeutics Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Glaucoma Therapeutics Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glaucoma Therapeutics Devices Sales Growth
4.4 APAC Glaucoma Therapeutics Devices Sales Growth
4.5 Europe Glaucoma Therapeutics Devices Sales Growth
4.6 Middle East & Africa Glaucoma Therapeutics Devices Sales Growth
5 Americas
5.1 Americas Glaucoma Therapeutics Devices Sales by Country
5.1.1 Americas Glaucoma Therapeutics Devices Sales by Country (2020-2025)
5.1.2 Americas Glaucoma Therapeutics Devices Revenue by Country (2020-2025)
5.2 Americas Glaucoma Therapeutics Devices Sales by Type (2020-2025)
5.3 Americas Glaucoma Therapeutics Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glaucoma Therapeutics Devices Sales by Region
6.1.1 APAC Glaucoma Therapeutics Devices Sales by Region (2020-2025)
6.1.2 APAC Glaucoma Therapeutics Devices Revenue by Region (2020-2025)
6.2 APAC Glaucoma Therapeutics Devices Sales by Type (2020-2025)
6.3 APAC Glaucoma Therapeutics Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glaucoma Therapeutics Devices by Country
7.1.1 Europe Glaucoma Therapeutics Devices Sales by Country (2020-2025)
7.1.2 Europe Glaucoma Therapeutics Devices Revenue by Country (2020-2025)
7.2 Europe Glaucoma Therapeutics Devices Sales by Type (2020-2025)
7.3 Europe Glaucoma Therapeutics Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glaucoma Therapeutics Devices by Country
8.1.1 Middle East & Africa Glaucoma Therapeutics Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Glaucoma Therapeutics Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Glaucoma Therapeutics Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Glaucoma Therapeutics Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glaucoma Therapeutics Devices
10.3 Manufacturing Process Analysis of Glaucoma Therapeutics Devices
10.4 Industry Chain Structure of Glaucoma Therapeutics Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glaucoma Therapeutics Devices Distributors
11.3 Glaucoma Therapeutics Devices Customer
12 World Forecast Review for Glaucoma Therapeutics Devices by Geographic Region
12.1 Global Glaucoma Therapeutics Devices Market Size Forecast by Region
12.1.1 Global Glaucoma Therapeutics Devices Forecast by Region (2026-2031)
12.1.2 Global Glaucoma Therapeutics Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glaucoma Therapeutics Devices Forecast by Type (2026-2031)
12.7 Global Glaucoma Therapeutics Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Alcon
13.1.1 Alcon Company Information
13.1.2 Alcon Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.1.3 Alcon Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alcon Main Business Overview
13.1.5 Alcon Latest Developments
13.2 Carl Zeiss Meditec AG
13.2.1 Carl Zeiss Meditec AG Company Information
13.2.2 Carl Zeiss Meditec AG Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.2.3 Carl Zeiss Meditec AG Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Carl Zeiss Meditec AG Main Business Overview
13.2.5 Carl Zeiss Meditec AG Latest Developments
13.3 Johnson & Johnson Vision
13.3.1 Johnson & Johnson Vision Company Information
13.3.2 Johnson & Johnson Vision Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.3.3 Johnson & Johnson Vision Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Vision Main Business Overview
13.3.5 Johnson & Johnson Vision Latest Developments
13.4 Bausch Health Companies Inc.
13.4.1 Bausch Health Companies Inc. Company Information
13.4.2 Bausch Health Companies Inc. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.4.3 Bausch Health Companies Inc. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bausch Health Companies Inc. Main Business Overview
13.4.5 Bausch Health Companies Inc. Latest Developments
13.5 Glaukos Corporation
13.5.1 Glaukos Corporation Company Information
13.5.2 Glaukos Corporation Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.5.3 Glaukos Corporation Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Glaukos Corporation Main Business Overview
13.5.5 Glaukos Corporation Latest Developments
13.6 Topcon Corporation
13.6.1 Topcon Corporation Company Information
13.6.2 Topcon Corporation Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.6.3 Topcon Corporation Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Topcon Corporation Main Business Overview
13.6.5 Topcon Corporation Latest Developments
13.7 STAAR Surgical Company
13.7.1 STAAR Surgical Company Company Information
13.7.2 STAAR Surgical Company Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.7.3 STAAR Surgical Company Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 STAAR Surgical Company Main Business Overview
13.7.5 STAAR Surgical Company Latest Developments
13.8 NIDEK CO., LTD.
13.8.1 NIDEK CO., LTD. Company Information
13.8.2 NIDEK CO., LTD. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.8.3 NIDEK CO., LTD. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NIDEK CO., LTD. Main Business Overview
13.8.5 NIDEK CO., LTD. Latest Developments
13.9 Lumenis Ltd.
13.9.1 Lumenis Ltd. Company Information
13.9.2 Lumenis Ltd. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.9.3 Lumenis Ltd. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lumenis Ltd. Main Business Overview
13.9.5 Lumenis Ltd. Latest Developments
13.10 Ophthalmic Instrument Company
13.10.1 Ophthalmic Instrument Company Company Information
13.10.2 Ophthalmic Instrument Company Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.10.3 Ophthalmic Instrument Company Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ophthalmic Instrument Company Main Business Overview
13.10.5 Ophthalmic Instrument Company Latest Developments
13.11 New World Medical, Inc.
13.11.1 New World Medical, Inc. Company Information
13.11.2 New World Medical, Inc. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.11.3 New World Medical, Inc. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 New World Medical, Inc. Main Business Overview
13.11.5 New World Medical, Inc. Latest Developments
13.12 Ellex Medical Lasers Limited
13.12.1 Ellex Medical Lasers Limited Company Information
13.12.2 Ellex Medical Lasers Limited Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.12.3 Ellex Medical Lasers Limited Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Ellex Medical Lasers Limited Main Business Overview
13.12.5 Ellex Medical Lasers Limited Latest Developments
13.13 Iridex Corporation
13.13.1 Iridex Corporation Company Information
13.13.2 Iridex Corporation Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.13.3 Iridex Corporation Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Iridex Corporation Main Business Overview
13.13.5 Iridex Corporation Latest Developments
13.14 Abbvie Inc.
13.14.1 Abbvie Inc. Company Information
13.14.2 Abbvie Inc. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.14.3 Abbvie Inc. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Abbvie Inc. Main Business Overview
13.14.5 Abbvie Inc. Latest Developments
13.15 Reichert Technologies
13.15.1 Reichert Technologies Company Information
13.15.2 Reichert Technologies Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.15.3 Reichert Technologies Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Reichert Technologies Main Business Overview
13.15.5 Reichert Technologies Latest Developments
13.16 Ziemer Ophthalmic Systems
13.16.1 Ziemer Ophthalmic Systems Company Information
13.16.2 Ziemer Ophthalmic Systems Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.16.3 Ziemer Ophthalmic Systems Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ziemer Ophthalmic Systems Main Business Overview
13.16.5 Ziemer Ophthalmic Systems Latest Developments
13.17 Optovue, Inc.
13.17.1 Optovue, Inc. Company Information
13.17.2 Optovue, Inc. Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.17.3 Optovue, Inc. Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Optovue, Inc. Main Business Overview
13.17.5 Optovue, Inc. Latest Developments
13.18 Heidelberg Engineering GmbH
13.18.1 Heidelberg Engineering GmbH Company Information
13.18.2 Heidelberg Engineering GmbH Glaucoma Therapeutics Devices Product Portfolios and Specifications
13.18.3 Heidelberg Engineering GmbH Glaucoma Therapeutics Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Heidelberg Engineering GmbH Main Business Overview
13.18.5 Heidelberg Engineering GmbH Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂